Details for Patent: 10,646,512
✉ Email this page to a colleague
Which drugs does patent 10,646,512 protect, and when does it expire?
Patent 10,646,512 protects PLENVU and is included in one NDA.
This patent has sixty-nine patent family members in thirty-four countries.
Drugs Protected by US Patent 10,646,512
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salix | PLENVU | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate | FOR SOLUTION;ORAL | 209381-001 | May 4, 2018 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,646,512
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3141251 | ⤷ Subscribe | 122021000018 | Germany | ⤷ Subscribe |
| European Patent Office | 3141251 | ⤷ Subscribe | 132021000000044 | Italy | ⤷ Subscribe |
| European Patent Office | 3141251 | ⤷ Subscribe | 301099 | Netherlands | ⤷ Subscribe |
| European Patent Office | 3141251 | ⤷ Subscribe | C202130017 | Spain | ⤷ Subscribe |
| European Patent Office | 3141251 | ⤷ Subscribe | SPC/GB20/075 | United Kingdom | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
